Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies
By N. Sarwar, Mphil, John Danesh, Dphil, G. Eiriksdottir, G. Sigurdsson, N. Wareham, S. Bingham, S. Matthijs Boekholdt, Kay-Tee Khaw and 1 more. Circulation, 2007
1,485 citations recorded by the source corpus.
Subfields: Cancer Research, Endocrinology, Diabetes and Metabolism, Epidemiology
View Paper: https://www.semanticscholar.org/paper/b7786c32ed25c64a9c47f048e08fffbd1c0168bb
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Endocrinology, Diabetes and Metabolism
- I. Graham
- Massimo F. Piepoli
- Alberico L. Catapano
- Børge G. Nordestgaard
- T. Ivanova
- L. Rydén
- R. Goldberg
In Epidemiology
- I. Graham
- Børge G. Nordestgaard
- Massimo F. Piepoli
- Jose Luis Zamorano
- E. Braunwald
- R. Goldberg
- Alberico L. Catapano
- P. Calder
Citations in the corpus
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice (2016, background): “4 Triglycerides Hypertriglyceridaemia is a significant independent CVD risk factor, but the association is far weaker than for hypercholesterolaemia.(358) The risk is associated more strongly with moderate than with very severe hypertriglyceridaemia [.”
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice. (2016, background): “4 Triglycerides Hypertriglyceridaemia is a significant independent CVD risk factor, but the association is far weaker than for hypercholesterolaemia.(358) The risk is associated more strongly with moderate than with very severe hypertriglyceridaemia [.”
- Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology. (2016, positive): “This was confirmed in later meta-analyses.(50) In 2007 to 2008, studies from the Copenhagen City Heart Study and the Women’s Health Study showed that particularly elevated nonfasting triglycerides were associated with high risk of ASCVD, that is, for myocardial infarction (MI), ischemic heart diseas”
- Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. (2008, methodology): “Nevertheless, lthough standard statistical methods were used to account or known variability, a recent evaluation of repeat TG easurements over a 4- or 12-year period (n 2,312) dentified long-term stability of TG that was similar to lood pressure and other lipid measurements (6).”
- The heart's content: the association between positive psychological well-being and cardiovascular health. (2012, background): “, high levels of total cholesterol, low levels of HDL cholesterol, high levels of LDL cholesterol, and high levels of triglycerides) is well-established (Gordon, Castelli, Hjortland, Kannel, & Dawber, 1977; Sarwar et al., 2007; Stamler et al., 2000).”
- Lipoprotein Management in Patients With Cardiometabolic Risk (2008, background): “Although increased triglycerides are modestly associated with increased CVD risk, especially in women (75), it has been difficult to demonstrate that lowering of triglyceride levels is independently associated with a reduction in CVD events.”